125 related articles for article (PubMed ID: 10365730)
41. Reversible edema in a male patient taking parenteral pantoprazole infusion for pyloric stenosis.
Sennaroglu E; Karakan S; Kayatas M; Akdur S; Genc H; Karakan T; Ucler R; Ozisler C; Urun Y
Dig Dis Sci; 2006 Jan; 51(1):121-2. PubMed ID: 16416223
[No Abstract] [Full Text] [Related]
42. What is potent acid inhibition, and how can it be achieved?
Calvet X; Gomollón F
Drugs; 2005; 65 Suppl 1():13-23. PubMed ID: 16335854
[TBL] [Abstract][Full Text] [Related]
43. Discoloured tongue: a new cause?
Scully C
Br J Dermatol; 2001 Jun; 144(6):1293-4. PubMed ID: 11422078
[No Abstract] [Full Text] [Related]
44. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
Ogawa N
Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
[TBL] [Abstract][Full Text] [Related]
45. Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.
Röhss K; Lind T; Wilder-Smith C
Eur J Clin Pharmacol; 2004 Oct; 60(8):531-9. PubMed ID: 15349707
[TBL] [Abstract][Full Text] [Related]
46. Treatment of acid peptic disease: focus on proton pump inhibitors. Proceedings of the 1st International Symposium on Lansoprazole. Athens, Greece, 24 September 1992.
Aliment Pharmacol Ther; 1993; 7 Suppl 1():1-75. PubMed ID: 8098225
[No Abstract] [Full Text] [Related]
47. Lansoprazole: a proton pump inhibitor.
Garnett WR
Ann Pharmacother; 1996 Dec; 30(12):1425-36. PubMed ID: 8968456
[TBL] [Abstract][Full Text] [Related]
48. Intravenous lansoprazole: in erosive oesophagitis.
Dando TM; Plosker GL
Drugs; 2004; 64(18):2085-9; discussion 2090. PubMed ID: 15341501
[TBL] [Abstract][Full Text] [Related]
49. Once or twice daily doses of proton pump inhibitor in treating Barrett's esophagus?
Savarino V; Mela GS; Zentilin P; Celle G; Vigneri S
Am J Gastroenterol; 1995 May; 90(5):845-6. PubMed ID: 7733108
[No Abstract] [Full Text] [Related]
50. [Proton pump blockers and their significance in gastroenterology].
Dítĕ P; Prásek J
Vnitr Lek; 1995 Aug; 41(8):549-54. PubMed ID: 7483340
[TBL] [Abstract][Full Text] [Related]
51. Acid-suppressive effects of rabeprazole, omeprazole, and lansoprazole at reduced and standard doses: a crossover comparative study in homozygous extensive metabolizers of cytochrome P450 2C19.
Shimatani T; Inoue M; Kuroiwa T; Xu J; Mieno H; Nakamura M; Tazuma S
Clin Pharmacol Ther; 2006 Jan; 79(1):144-52. PubMed ID: 16413249
[TBL] [Abstract][Full Text] [Related]
52. Barrett's esophagus: acid suppression, but no regression.
Bozymski EM; Shaheen NJ
Am J Gastroenterol; 1997 Apr; 92(4):556-8. PubMed ID: 9128299
[No Abstract] [Full Text] [Related]
53. Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole.
Levine A; Shevah O; Shabat-Sehayek V; Aeed H; Boaz M; Moss SF; Niv Y; Avni Y; Shirin H
Aliment Pharmacol Ther; 2004 Jul; 20(1):117-22. PubMed ID: 15225178
[TBL] [Abstract][Full Text] [Related]
54. An extensive metabolizer with recurrent ulcer responding to high dose of lansoprazole.
Higuchi K; Tanabe S; Koizumi W; Nakayama N; Sasaki T; Nagaba S; Saigenji K; Katada N
Hepatogastroenterology; 2004; 51(57):774-6. PubMed ID: 15143914
[TBL] [Abstract][Full Text] [Related]
55. [Drug interactions. Proton pump inhibitors II].
Zaigler M
Internist (Berl); 1998 Sep; 39(9):978-9. PubMed ID: 9788120
[No Abstract] [Full Text] [Related]
56. [Lansoprazol ++ : a new proton pump inhibitor].
Baczek J; Laskowiec G
Pol Merkur Lekarski; 1998 Jun; 4(24):339-41. PubMed ID: 9771021
[TBL] [Abstract][Full Text] [Related]
57. [Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial].
Petite JP; Slama JL; Licht H; Lemerez M; Coste T; Andrieu J; Grimaud JC; Julien H; Dupuis J; Sallerin V
Gastroenterol Clin Biol; 1993; 17(5):334-40. PubMed ID: 8349067
[TBL] [Abstract][Full Text] [Related]
58. Lansoprazole--another proton pump inhibitor.
Drug Ther Bull; 1995 May; 33(5):36-7. PubMed ID: 7587993
[No Abstract] [Full Text] [Related]
59. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
60. Esomeprazole: a review of its use in the management of acid-related disorders in the US.
Scott LJ; Dunn CJ; Mallarkey G; Sharpe M
Drugs; 2002; 62(7):1091-118. PubMed ID: 11985491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
